abstract |
The present invention relates to pharmaceutical therapy using agonists of retinoic acid receptor-related orphan receptor gamma (RORγ), adoptive cell therapy using agonists of RORγ, populations of lymphocyte cells exposed to agonists of RORγ, RORγ A population of dendritic cells, a pharmaceutical composition, and a method of increasing the therapeutic effect of lymphocyte cells and / or dendritic cells in a patient by administering to the patient an agonist of RORγ is provided. |